Tumor-derived exosomes (T-EXOs), containing immune-modulatory molecules like TGF-β and cGAMP, activate STING in tumor-infiltrating lymphocytes by delivering tumor-associated DNA and proteins. Here, TGFB1 is linked to neoplasm.